PCBL Chemical Ltd Q4 FY25 Earnings Analysis
Published 20 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹13.0K Cr
Price
₹327
Market Cap
₹13.0K Cr
P/E Ratio
49.0
How does PCBL Chemical Ltd rank in Chemicals & Petrochemicals?
Compare PCBL Chemical Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
PCBL Chemical Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹40 Cr.
Full financials →Earnings Summary
Aquapharm aims for 15-20% volume growth maintained going forward with strong demand in oil & gas and detergent chemicals sectors. PCBL expects about 9%-10% volume growth in Carbon Black for FY '26, targeting around 650,000 tons. - EBITDA per metric ton in Carbon Black aims to improve from ~Rs.17,655 currently to Rs.
📊 Revenue & Sales Performance
- →Aquapharm aims for 15-20% volume growth maintained going forward with strong demand in oil & gas and detergent chemicals sectors.
- →Focus on significantly increasing sales in the USA market due to strong demand and margins; Europe is stable but less dynamic.
- →Overall Carbon Black volume expected to grow 9-10% in FY '26, reaching around 650,000 tons, driven by export market expansion.
- →Addition of 90,000 MT capacity in Tamil Nadu and upcoming Andhra Pradesh greenfield project to support volume growth.
- →Specialty Carbon Black volume and portfolio expansion targeted to improve EBITDA margin.
- →Aquapharm targeting almost 50% EBITDA growth in the current financial year.
- →Long-term Carbon Black EBITDA target is Rs. 25,000/MT with improvements from operating leverage, new capacities, and product portfolio shifts.
- →Export volumes are a key growth driver amid muted domestic demand for Carbon Black.
📈 Profitability & Margins
- →PCBL expects about 9%-10% volume growth in Carbon Black for FY '26, targeting around 650,000 tons.
- →EBITDA per metric ton in Carbon Black aims to improve from ~Rs.17,655 currently to Rs. 25,000 in 3-4 years through operating leverage, product mix enhancement, and specialty volume growth.
- →Aquapharm segment anticipates nearly 50% EBITDA growth in FY '26 backed by green shoots in oil & gas and detergent chemicals.
- →Aquapharm achieved Rs. 194 crores EBITDA in FY '25 and expects substantial improvement going forward.
- →Overall consolidated EBITDA grew 28.8% YoY to Rs. 1,384 crores in FY '25; company targets further growth with new capacities and improved product portfolio.
- →Operating leverage from capacity expansions (90,000 MT in Tamil Nadu plus upcoming Brownfield and Greenfield projects) will boost margins and earnings.
- →Interest costs expected to reduce with falling rates, aiding net profits.
- →Company confident of doubling market share from 4% to 8-12% over time, indicating strong long-term growth potential.
🏗️ Capital Expenditure Plans
- →PCBL is undertaking a Greenfield plant project in Andhra Pradesh with 116 acres acquired in Naidupeta, focusing primarily on rubber black, performance, and specialty chemicals; this site can eventually accommodate 450,000 MTPA additional capacity. Capex expected to commence in a year, with construction taking 18 months.
- →A Greenfield plant in Tamil Nadu is underway, adding 90,000 MT capacity this year, mostly rubber grade carbon black, benefiting from a favorable tax regime (17.2% tax rate).
- →Specialty Carbon Black capacity expanded by 20,000 MT in FY '25 with plans for another line in next 12-15 months.
- →Nanovace Technologies pilot plant for nano-silicon in lithium-ion batteries is under construction at Palej; commercial plant expected mid FY '28.
- →Expansion of Aquapharm Chemicals in the USA, including local manufacturing in Texas, with capacity commissioned recently and targeting 15-20% volume growth.
- →Total Capex pipeline about Rs. 3,500 crore over 5 years, averaging Rs. 700 crore annually.
💰 Fundraising & Capital Structure
- →PCBL Chemical Limited plans to spend around Rs. 3,500 crores on Capex over the next 5 years, averaging about Rs. 700 crore per year.
- →The company expects to generate good cash flow but does not anticipate a significant reduction in absolute debt levels in FY '26 and '27 due to ongoing Capex commitments.
- →Debt is entirely rupee denominated; no indication of foreign currency debt exposure.
- →With interest rates expected to cool down, finance costs are anticipated to decrease, but no explicit mention of new fundraising through debt or equity in the near term.
- →Current strategy focuses on managing cash flows and Capex without major changes in debt levels rather than new fundraising.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were PCBL Chemical Ltd Q4 FY25 results?
Aquapharm aims for 15-20% volume growth maintained going forward with strong demand in oil & gas and detergent chemicals sectors. PCBL expects about 9%-10% volume growth in Carbon Black for FY '26, targeting around 650,000 tons. - EBITDA per metric ton in Carbon Black aims to improve from ~Rs.17,655 currently to Rs.
What is PCBL Chemical Ltd share price analysis?
PCBL Chemical Ltd currently shows a neutral. The stock trades at a P/E of 49.0 with a market cap of ₹12,963 Cr. Investors should review the full earnings analysis for detailed insights.
Is PCBL Chemical Ltd planning capital expenditure?
PCBL is undertaking a Greenfield plant project in Andhra Pradesh with 116 acres acquired in Naidupeta, focusing primarily on rubber black, performance, and specialty chemicals; this site can eventually accommodate 450,000 MTPA additional capacity.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.